During 2020 to 2021, more than 10 percent increase seen in percentage of women aged 15 to 44 years, men aged 25 to 44 years with prescription fills
United States Exceeds Western Europe for Excess Deaths
While COVID-19 drove this excess in 2021, nearly half of excess deaths were from other causes
Emergency Visits for Firearm Injuries Higher During Pandemic
Average number of weekly emergency department visits was 36, 37, and 20 percent higher in 2020, 2021, 2022 than in 2019
HSV Treatment Readies for Approval
A recently published Original Article reported positive news regarding the First-in-Human clinical trials assessing Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor targeting the Herpes Simplex Virus (HSV).
As an active ingredient in a new chemical class (thiazolylamides), Pritelivir is active against both types of herpes, HSV-1 and HSV-2.
Published on March 1, 2023, a peer-reviewed study disclosed Pritelivir was evaluated in five phase 1 trials, a single-ascending-dose trial, two multiple-ascending-dose trials, and others.
Fatal Drug Overdose Down With OUD-Related Telehealth Services
Furthermore, risk for fatal drug overdose lower with receipt of medications for opioid use disorder from opioid treatment programs
WHO: Healthy Children, Teens May Not Need More COVID-19 Shots
Instead, COVID-19 vaccines should go to high-risk people, according to the agency’s Strategic Advisory Group of Experts on Immunization
Nets Treated with Pyrethroid-Chlorfenapy Recommended During Malaria Outbreaks
The World Health Organization (WHO) recently updated its malaria policy guidelines to recommend using long-lasting insecticidal nets (LLINs) treated with a combination of insecticides, which researchers say could be a game-changer in the global fight against the disease if managed effectively.
The WHO now recommends that malaria-endemic regions experiencing pyrethroid resistance switch to the more effective pyrethroid-chlorfenapyr nets.
Adverse Postoperative Outcomes Not Increased With Recent COVID-19
Odds ratios for postoperative outcomes not significantly increased for those with infection in preoperative days 1 to 30, 31 to 60
Daily Step Counts Declined With Onset of Pandemic
Factors including vaccination status, depression, psychological stress partially explain reduction in step counts
New Dengue Vaccine Pricing Disclosed
As the new tetravalent dengue fever vaccine from Takeda Pharmaceutical Company rapidly gains approvals around the globe, many interested parties were asking what this innovative disease protection would cost.
'We aim to make QDENGA® available to all eligible for vaccination in the countries where approved,' stated Takeda's presentation led by Ramona Sequeira, President, Global Portfolio Division, on March 15, 2023.
For example, Takeda disclosed these classifications: